Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Survodutide

SYNCHRONIZE™JP

Boehringer Ingelheim · Phase 3 · Completed · Enrollment 274

NCT06176365

ArmPopulationDoseWeeksEstimandWeight change
Survodutide - 3.6 mgObesity or overweight3.6 mgn/rn/rn/r
Survodutide - 6.0 mgObesity or overweight6.0 mgn/rn/rn/r
Placebo groupObesity or overweightn/rn/rn/rn/r